These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 15339899)

  • 1. Do tumors detected by mammography screening have a favorable prognosis?
    O'Regan RM
    JAMA; 2004 Sep; 292(9):1062-3. PubMed ID: 15339899
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk for distant recurrence of breast cancer detected by mammography screening or other methods.
    Joensuu H; Lehtimäki T; Holli K; Elomaa L; Turpeenniemi-Hujanen T; Kataja V; Anttila A; Lundin M; Isola J; Lundin J
    JAMA; 2004 Sep; 292(9):1064-73. PubMed ID: 15339900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathologic discriminants of breast cancers detected on screening by mammography and physical examination.
    Feig SA; Schwartz GF
    Cancer Detect Prev; 1981; 4(1-4):579-88. PubMed ID: 7349824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer of the breast: the past decade (first of two parts).
    Henderson IC; Canellos GP
    N Engl J Med; 1980 Jan; 302(1):17-30. PubMed ID: 6985698
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening for breast cancer.
    Duffy SW; Smith RA; Gabe R; Tabár L; Yen AM; Chen TH
    Surg Oncol Clin N Am; 2005 Oct; 14(4):671-97. PubMed ID: 16226686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammography in 40-year-old women: what difference does it make? The potential impact of the U.S. Preventative Services Task Force (USPSTF) mammography guidelines.
    Shen N; Hammonds LS; Madsen D; Dale P
    Ann Surg Oncol; 2011 Oct; 18(11):3066-71. PubMed ID: 21863364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The screening mammography paradox: better when found, perhaps better not to find.
    Berry DA
    Br J Cancer; 2008 Jun; 98(11):1729-30. PubMed ID: 18506172
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship between method of detection of breast cancer and stage of disease, method of treatment, and survival in women aged 40 to 49 years.
    Maibenco D; Daoud Y; Phillips E; Saxe A
    Am Surg; 1999 Nov; 65(11):1061-6. PubMed ID: 10551757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are prognostic factors more favorable for breast cancer detected by organized screening than by opportunistic screening or clinical diagnosis? A study in Loire-Atlantique (France).
    Vanier A; Leux C; Allioux C; Billon-Delacour S; Lombrail P; Molinié F
    Cancer Epidemiol; 2013 Oct; 37(5):683-7. PubMed ID: 23880147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Breast cancer-a brief review of our present knowledge (author's transl)].
    Wewerka J
    Schweiz Rundsch Med Prax; 1981 Jun; 70(24):1103-10. PubMed ID: 7019881
    [No Abstract]   [Full Text] [Related]  

  • 11. A rational approach to early breast cancer.
    O'Kelly WB
    J Miss State Med Assoc; 1977 Mar; 18(3):55-6. PubMed ID: 859173
    [No Abstract]   [Full Text] [Related]  

  • 12. [Breast tumor with myoepithelial cells. Apropos of a case report].
    Brasseur P; Hustin J; Collard M
    J Belge Radiol; 1990 Jun; 73(3):197-200. PubMed ID: 2166026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and self breast examination remain important in the era of modern screening.
    Ma I; Dueck A; Gray R; Wasif N; Giurescu M; Lorans R; Pizzitola V; Pockaj B
    Ann Surg Oncol; 2012 May; 19(5):1484-90. PubMed ID: 22160521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage distribution of breast cancer diagnosed before and after implementation of population-based mammographic screening.
    Hofvind S; Skaane P
    Rofo; 2012 May; 184(5):437-42. PubMed ID: 22426937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed benefit of mammography screening in premenopausal women.
    Jatoi I; Soballe PW; Anderson WF
    J Clin Oncol; 2004 Dec; 22(23):4860; author reply 4860-2. PubMed ID: 15570095
    [No Abstract]   [Full Text] [Related]  

  • 16. DNA ploidy in screening-detected non-palpable mammary carcinomas.
    von Rosen A; Frisell J; Azavedo E; Auer G
    Eur J Surg Oncol; 1990 Dec; 16(6):471-4. PubMed ID: 2174806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [40 years breast carcinoma treatment in the Neubrandenburg region.Can an increase in prognostically more favorable stages be detected?].
    Rühle H; Grobe N; Balschat S; Ernst KF; Dewitz D; Winkler L
    Z Arztl Fortbild Qualitatssich; 1997 Mar; 91(2):135-7. PubMed ID: 9244654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current management of primary breast cancer. Part I: Screening, diagnosis, staging and local treatment of stage I and II disease.
    Lopez MJ; Andriole DP
    Mo Med; 1990 Sep; 87(9):684-90. PubMed ID: 2215472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should we screen BRCA1 mutation carriers only with MRI? A multicenter study.
    Obdeijn IM; Winter-Warnars GA; Mann RM; Hooning MJ; Hunink MG; Tilanus-Linthorst MM
    Breast Cancer Res Treat; 2014 Apr; 144(3):577-82. PubMed ID: 24567197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast density: the trend in breast cancer screening.
    Machida Y; Tozaki M; Shimauchi A; Yoshida T
    Breast Cancer; 2015 May; 22(3):253-61. PubMed ID: 25784189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.